Regulatory Capture — Conflicts of Interest on FDA and CDC Vaccine Committees
FDA regulatory capture by the pharmaceutical industry: documented evidence of industry influence over vaccine and drug regulation, from user fee dependence to the revolving door.
The phenomenon whereby the agencies charged with regulating an industry become dominated by individuals with financial ties to that industry — undermining their independence and the integrity of their decisions. In the context of vaccine policy, Aaron Siri argues that FDA's vaccine committee (VRBPAC) and CDC's vaccine committee (ACIP) were captured by pharma-affiliated vaccinologists who simultaneously conducted industry-funded trials, voted to license and recommend those same vaccines, and received ongoing payments from the companies whose products they regulated.
Explanation
The regulatory pathway for childhood vaccines runs through two key committees:
1. FDA's VRBPAC — advises on vaccine licensure
2. CDC's ACIP — recommends vaccines for the childhood schedule
States then mandate vaccines based on the ACIP schedule.
Regulatory capture occurs when the people on these committees have substantial financial ties to the companies whose products they are evaluating — creating conflicts of interest that compromise objectivity, whether consciously or not.
A Congressional investigation titled "Conflicts of Interest in Vaccine Policy Making" (June 15, 2000) found:
FDA's VRBPAC: "The overwhelming majority of members, both voting members and consultants, have substantial ties to the pharmaceutical industry."
CDC's ACIP: Equally condemned.
"Loose standards" — "significant conflicts of interest are not deemed to be conflicts"
"Government officials make crucial decisions affecting American children without the advice and consent of the governed."
The report noted it identified only a fraction of actual conflicts. The Kathryn Edwards case demonstrates this: the report identified only her $255,023/year Wyeth Lederle contract and missed her far more extensive conflicts.
Plotkin attended virtually every ACIP meeting for six decades while simultaneously:
Consulting for, sitting on boards of, and receiving royalties from Merck, Pfizer, Sanofi, and GSK
Working on vaccine development for these companies
Having his name on the ACIP gavel
The Triple Conflict
Siri documents that the same small group of vaccinologists: (1) conducted pharma-funded clinical trials, (2) sat on FDA/CDC committees that voted to license and recommend those vaccines, AND (3) worked as consultants/board members for the same pharma companies. This triple conflict describes Kathryn Edwards, Stanley Plotkin, and, by extension, the broader protégé network.
2008 HHS Inspector General Report
A follow-up investigation by the HHS Inspector General in 2008 found even more pervasive conflicts than the 2000 Congressional report, including:
"CDC had a systemic lack of oversight of the ethics program"
58% of committee members had potential conflicts of interest that CDC did not identify
32% had potential conflicts of interest that CDC identified but did not resolve
The Structural Conflict: HHS as Defendant
Beyond individual committee member conflicts, Siri argues that HHS itself is structurally captured by design. Under the 1986 Act (National Childhood Vaccine Injury Act), HHS must simultaneously promote vaccines, assure their safety, and legally defend against all vaccine injury claims through the VICP. This means HHS has a direct institutional incentive never to publish studies finding that a vaccine causes harm — since those studies would be used against HHS in vaccine court.
The "Pharma Selection" Mechanism
Siri describes how pharma captures vaccinologists not through overt corruption but through career incentives: vaccinologists who deviate from vaccine orthodoxy don't receive pharma research funding, aren't invited to participate in trials, and are excluded from coveted journal and institutional positions. Those whose views align with pharma interests receive patronage and rise. Siri terms this "pharma selection." The result is a self-reinforcing closed system.
Significance
If the people who decide which vaccines are licensed and recommended have financial ties to the companies that profit from those decisions, those decisions cannot be considered independent. Siri argues this structural conflict is not incidental but systematic — and that it explains why pre-licensure safety testing is so minimal and post-licensure safety studies are so rarely funded.
Is the FDA captured by the pharmaceutical industry and what is the evidence?
A 2000 Congressional investigation found that "the overwhelming majority of members, both voting members and consultants, have substantial ties to the pharmaceutical industry" on FDA's vaccine advisory committee (VRBPAC). A 2008 HHS Inspector General report found 58% of committee members had potential conflicts of interest that CDC did not identify, and 32% had conflicts CDC identified but did not resolve. The same individuals who conducted pharma-funded clinical trials sat on committees that voted to license those same vaccines.
What is the revolving door between the FDA and pharmaceutical companies?
The revolving door describes officials moving between regulatory agencies and the companies they regulate. Julie Gerberding left the CDC directorship to become Merck's President of Vaccines, ultimately cashing in over $22 million in Merck stock. Stanley Plotkin consulted for Merck, Pfizer, Sanofi, and GSK for decades while attending virtually every ACIP meeting. This pattern creates career incentives that align regulator behavior with industry interests.
How does pharma selection work in vaccine regulatory capture?
Pharma captures vaccinologists not through overt corruption but through career incentives. Researchers whose views align with industry interests receive pharma research funding, trial invitations, journal positions, and institutional appointments. Those who deviate from vaccine orthodoxy lose funding and are excluded. The result is a self-reinforcing closed system where only industry-aligned researchers rise to positions of influence on advisory committees.
What did the 2008 HHS Inspector General report find about CDC conflicts?
The Inspector General found even more pervasive conflicts than the 2000 Congressional report: CDC had a "systemic lack of oversight of the ethics program," 58% of committee members had potential conflicts of interest that CDC did not identify, and 32% had conflicts CDC identified but did not resolve. These are the committees that set the childhood vaccine schedule affecting every American child.
Why is HHS structurally captured by design according to Aaron Siri?
Under the 1986 Act, HHS must simultaneously promote vaccines, assure their safety, and legally defend against all vaccine injury claims through the VICP. If HHS published a study showing a vaccine causes harm, that study would be used against HHS in vaccine court. This creates a direct institutional incentive never to fund, conduct, or publish studies finding vaccine harms — a structural conflict encoded in federal law.
This is the plain-HTML rendering of concepts/Regulatory Capture.md, served for search
engines, AI crawlers, and accessibility tools. The interactive 3D version
of this wiki lives at vaccine-safety.org.